POGGIALINI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 2.031
AS - Asia 1.319
NA - Nord America 1.306
SA - Sud America 277
AF - Africa 32
OC - Oceania 3
Totale 4.968
Nazione #
US - Stati Uniti d'America 1.246
RU - Federazione Russa 722
IT - Italia 620
SG - Singapore 474
CN - Cina 354
BR - Brasile 238
IE - Irlanda 167
KR - Corea 125
DE - Germania 122
GB - Regno Unito 101
HK - Hong Kong 100
VN - Vietnam 78
IN - India 66
FR - Francia 53
SE - Svezia 45
FI - Finlandia 32
NL - Olanda 32
MX - Messico 27
CA - Canada 25
ES - Italia 20
AT - Austria 19
JP - Giappone 19
BD - Bangladesh 18
CZ - Repubblica Ceca 17
UA - Ucraina 17
IR - Iran 16
EC - Ecuador 13
PL - Polonia 13
TR - Turchia 13
ZA - Sudafrica 13
AR - Argentina 11
BE - Belgio 9
PK - Pakistan 8
RO - Romania 8
PT - Portogallo 7
TN - Tunisia 7
ID - Indonesia 6
CI - Costa d'Avorio 5
LI - Liechtenstein 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
KZ - Kazakistan 4
MY - Malesia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
IQ - Iraq 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
UZ - Uzbekistan 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
PH - Filippine 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
TH - Thailandia 1
TV - Tuvalu 1
Totale 4.968
Città #
Dallas 359
Singapore 332
Moscow 214
Dublin 164
Hefei 149
Siena 148
Santa Clara 128
Seoul 116
Ashburn 106
Hong Kong 98
Milan 93
Beijing 82
Florence 77
New York 68
Los Angeles 49
Southend 47
Munich 46
Bengaluru 33
Rome 33
São Paulo 27
Fairfield 24
Chandler 22
Ho Chi Minh City 22
Lauterbourg 20
Chicago 19
Buffalo 15
Hanoi 15
Nuremberg 15
Portsmouth 15
Amsterdam 14
Boardman 13
Cambridge 13
Frankfurt am Main 13
Redondo Beach 13
Tokyo 13
Düsseldorf 12
Lappeenranta 12
London 12
Helsinki 11
Houston 11
Princeton 11
The Dalles 11
Vienna 11
Wilmington 11
Brno 10
Johannesburg 10
Orem 10
Rio de Janeiro 10
Jacksonville 9
Montreal 9
Stockholm 9
Woodbridge 9
Brasília 8
Cluj-Napoca 8
Guayaquil 8
Mexico City 8
Toronto 8
Ankara 7
Brescia 7
Brooklyn 7
Chennai 7
Dhaka 7
Naples 7
Seattle 7
Turku 7
Warsaw 7
Atlanta 6
Belo Horizonte 6
Bologna 6
Columbus 6
Denver 6
Ghent 6
Lisbon 6
Poplar 6
Salt Lake City 6
Salvador 6
Tehran 6
Tunis 6
Ann Arbor 5
Bagno a Ripoli 5
Cagliari 5
Da Nang 5
L’Aquila 5
New Delhi 5
Palermo 5
Piscataway 5
Querétaro 5
Quito 5
Santo André 5
Shanghai 5
Turin 5
Abidjan 4
Boston 4
Fremont 4
Hải Dương 4
Irpin 4
Kaohsiung 4
Leipzig 4
Manchester 4
Messina 4
Totale 3.069
Nome #
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 270
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 245
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides 233
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains 223
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth 216
Investigation of in vitro and in vivo pharmacokinetics and biological evaluation of pharmacologically active compounds 208
Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA 193
A Facile Access to Green Fluorescent Albumin Derivatives 184
Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy 156
A greener technique for microwave-assisted O-Silylation and silyl ether deprotection of uridine and other substrates 151
Tyrosine kinase inhibitor Si409 has in vitro and in vivo anti-tumor activity against diffuse large B-cell lymphoma 147
DEAD-Box Helicase DDX3X as a host target against emerging viruses: new insights for medicinal chemical approaches 145
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model 143
Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors 139
Efficient use of agricultural waste to naturally fortify Tenebrio molitor mealworms and evaluation of their nutraceutical properties 138
Exploiting the bile acid binding protein as transporter of a Cholic Acid/Mirin bioconjugate for potential applications in liver cancer therapy 137
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 130
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity 129
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme 128
Development and validation of derivatization-based LC-MS/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma 127
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 127
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 127
Exploiting fall foliage by-products to optimize Tenebrio molitor nutraceutical value 119
Progress towards adjuvant development: focus on antiviral therapy 119
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma 117
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 112
Sweet cherry extract as permeation enhancer of tyrosine kinase inhibitors: a promising prospective for future oral anticancer therapies 110
The replacement of flour-based feed with pellets reduces dustiness and improves tenebrio molitor breeders' safety 110
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 109
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 103
Upcycling Milk Industry Byproducts into Tenebrio molitor Larvae: Investigation on Fat, Protein, and Sugar Composition 98
Use of distillery by-products as Tenebrio molitor mealworm feed supplement 98
Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders 79
Infesting Seaweeds as a Novel Functional Food: Analysis of Nutrients, Antioxidants and ACE Inhibitory Effects 78
Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs 74
Exploitation of the Nutraceutical Potential of the Infesting Seaweed Chaetomorpha linum as a Yellow Mealworms’ Feed: Focus on Nutrients and Antioxidant Activity 67
ProTide-enabled antibody-drug conjugates: A novel platform for the targeted delivery of phosphorylated drugs 16
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment 12
Evaluation of anti-tumoral activity in 3D cell model of a Src inhibitor prodrug for glioblastoma treatment 8
Insects as Source of Nutraceuticals with Antioxidant, Antihypertensive, and Antidiabetic Properties: Focus on the Species Approved in Europe up to 2024 8
Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold 6
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents 5
Totale 5.144
Categoria #
all - tutte 14.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 8 8 15 3 7 3 5
2021/202290 3 9 6 2 3 3 2 2 6 15 15 24
2022/2023153 8 16 15 11 8 14 10 26 19 10 10 6
2023/2024565 27 15 28 35 28 98 121 31 10 35 38 99
2024/20251.683 57 44 146 132 183 94 120 128 162 94 166 357
2025/20262.487 276 466 403 508 793 41 0 0 0 0 0 0
Totale 5.144